Untreated Childhood Acute Lymphoblastic Leukemia (DBCOND0029289)

Identifiers

Synonyms

Not Available

Associated Data

Indicated Drugs and Targets

Not Available

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT00057811	Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma	Cyclophosphamide Cytarabine Doxorubicin Etoposide Filgrastim Hydrocortisone succinate Leucovorin Methotrexate Methylprednisolone Methylprednisolone hemisuccinate Prednisone Rasburicase Rituximab Sulfate ion Vincristine	treatment	2	completed
NCT00078858	Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant	Cyclosporine Fludarabine Mycophenolate mofetil	treatment	1 / 2	completed
NCT00014235	Fludarabine Phosphate and Total-Body Radiation Followed by Donor Peripheral Blood Stem Cell Transplant and Immunosuppression in Treating Patients With Hematologic Malignancies	Cyclosporine Fludarabine Mycophenolate mofetil	treatment	Not Available	completed
NCT00027820	Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer	Cyclosporine Fludarabine Mycophenolate mofetil	treatment	1 / 2	completed
NCT01625143	Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia	No drug interventions	Not Available	Not Available	completed
NCT00702403	Nilotinib and Imatinib Mesylate After Donor Stem Cell Transplant in Treating Patients With ALL or CML	Imatinib Nilotinib	treatment	1 / 2	completed
NCT00016302	Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Aspartic acid Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Doxorubicin Leucovorin Mercaptopurine Methotrexate Nelarabine Pegaspargase Prednisone Sulfate ion Tioguanine Vincristine	treatment	Not Available	completed
NCT00900445	Studying Body Mass Index in Younger Patients Who Are Receiving Treatment for High-Risk Acute Lymphoblastic Leukemia	Cortisone Daunorubicin Hydrocortisone Prednisolone Prednisone Sulfate ion Vincristine	Not Available	Not Available	withdrawn
NCT00061945	Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic Leukemia	Acyclovir Alemtuzumab Allopurinol Asparaginase Escherichia coli Cyclophosphamide Cytarabine Daunorubicin Dexamethasone Filgrastim Imatinib Leucovorin Mercaptopurine Methotrexate Sulfamethoxazole Trimethoprim Vincristine	treatment	1 / 2	completed
NCT00089011	Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer	Fludarabine Mycophenolate mofetil Tacrolimus	treatment	2	completed
NCT00482352	Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia	No drug interventions	Not Available	Not Available	completed
NCT00860574	Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia	Fludarabine Methotrexate Tacrolimus Treosulfan	treatment	2	completed
NCT00437060	Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia	No drug interventions	Not Available	Not Available	completed
NCT01406756	Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia	Asparaginase Escherichia coli Beta-D-Glucose Calcium Clofarabine Clofarabine Cortisone Cyclophosphamide Cytarabine Dexamethasone Doxorubicin Ethanol Etoposide Hydrocortisone Hydrocortisone succinate Leucovorin Levoleucovorin Mercaptopurine Methopterin Methotrexate Pegaspargase Prednisone Sodium succinate Sulfate ion Tioguanine Vincristine	treatment	3	recruiting